Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Kala Pharmaceuticals Inc (NQ: KALA )

15.05 +0.45 (+3.08%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 117,353
Open 14.52
Bid (Size) 14.70 (10)
Ask (Size) 15.00 (1)
Prev. Close 14.60
Today's Range 14.21 - 15.10
52wk Range 3.544 - 74.00
Shares Outstanding 2,025,495
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Kala Pharmaceuticals Appoints Dr. Francis Mah as Chief Medical Advisor
From Kala Pharmaceuticals, Inc.
Via Globe NewsWire
10 Short Squeeze Candidates: Unicycle Therapeutics, Compass Pathways, Virgin Orbit Among Those To Watch
Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits... 
Via Benzinga

Performance

YTD
-52.90%
-52.90%
1 Month
+57.92%
+57.92%
3 Month
-60.55%
-60.55%
6 Month
+35.95%
+35.95%
1 Year
-78.19%
-78.19%

More News

Read More
Kala Pharma Reveals Safety Data From Stem Cell Therapy Trial For Corneal Defect Impacting Around 240K People In Developed Nations
Via Benzinga
Kala Pharmaceuticals Announces Positive Safety Update from Cohort 1 of CHASE Phase 2b Clinical Trial Evaluating KPI-012 in Patients with PCED
From Kala Pharmaceuticals, Inc.
Via Globe NewsWire
Peering Into Kala Pharmaceuticals's Recent Short Interest
Via Benzinga
10 Short Squeeze Candidates: PaxMedica, Blue Apron, MicroStrategy And More
Via Benzinga
5 Short Squeeze Candidates To Watch: Ambrx Biopharma, Kala Pharmaceuticals And This Company That Moved Up 1,403 Positions
Via Benzinga
Kala Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference
From Kala Pharmaceuticals, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
10 Short Squeeze Candidates: China Jo-Jo Drugstores, Expion360, MoonLake, Silvergate And More
Via Benzinga
What's Going On With Kala Pharmaceuticals Shares Today
Via Benzinga
Kennedy-Wilson, Radian Group, BridgeBio Pharma And Other Big Stocks Moving Higher On Monday
Via Benzinga
What's Going On With Avalon GloboCare Shares Today
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Hertz Global Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Tesla, Nvidia, Ford, C3.ai, Kala Pharma: Why These 5 Stocks Are Drawing Investors' Attention Today
Via Benzinga
Kala Pharmaceuticals Stock Showing Rising Market Leadership; Earns 83 RS Rating
Via Investor's Business Daily
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
From Kala Pharmaceuticals, Inc.
Via Globe NewsWire
10 Short Squeeze Candidates To Watch This Week: Getty, Lannett, AirSculpt And More
Via Benzinga
7 Top Short-Squeeze Candidates to Watch in February
Via InvestorPlace
10 Short Squeeze Candidates To Watch This Week: Edible Garden, Getty Images And This Stock Moving Up 1,785 Places
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.